Ozempic, Wegovy, Monjouro, Zepbound – chances are you probably know someone who’s using one of these injectable weight-loss drugs. A recent large-scale study sponsored by the makers of Wegovy found the drug not only helped with weight loss, but also cut the risk of heart attack, cardiac-related death, and stroke.

During this American Heart Month, we’re asking, “Are these drugs good for your heart?” We talk with Dr. George Sokos, interim chair of the WVU Heart and Vascular Institute Department of Cardiology, to find out the answer to that question and more.